Globally, cervical cancer is the most appearing cancer in women. Cervical cancer is most frequently diagnosed in women between the age of 35 and 44 with the average age of diagnosis being 50. In 2019, an estimated 283.15 million women were diagnosed with cervical cancer worldwide, and about 311,000 women died from the disease in 2018. Cervical cancer is the fourth most common cancer prevailing in women and the seventh in terms of overall cancer incidences. There are three types of screening for identifying cervical cancer they are Pap Smear Tests, Human Papillomavirus Virus (HPV) Tests and Visual Inspection with Acetic Acid (VIA) Tests. These screenings are a key factor anticipated to boost the number of screening tests over the forecast period. Effective primary (HPV vaccination) approach (testing and treating precancerous lesions) will prevent most cervical cancer cases. According to this report, Cervical Cancer Screening Market is expected to be USD 16.5 Billion by 2026.
This report provides 19 Countries cervical cancer market analysis & forecast with numbers of screening & Mortality. In the United States, the medical community has made great strides in preventing and controlling cervical cancer. The reasons that influence world market dominance are the presence of technological advancements in terms of new diagnostic equipment, diagnostic procedures, favourable government policies related to reimbursement and screening techniques are expected to have a positive impact on the market. Cervical cancer is one of the leading causes of female cancer deaths in low- and middle-income countries.
COVID-19 impacts Global Cervical Cancer Screening Industry
The cervical cancer screening declined to meagre numbers due to pandemic coronavirus. Mostly non-urgent cervical cancer appointments have been cancelled in the wake of COVID-19. However, things started moving in the last two quarters, but it will not return to pre-COVID numbers this year. As preventive measures should put in place during the efforts of providing cervical cancer screening as directed by the health authorities. Read the complete analysis on how COVID-19 has affected the cervical cancer screening market and its future?
According to this report Cervical Cancer Market, Patients, Mortality Global Forecast by Tests (Pap Smear, HPV DNA, VIA), 19 Countries (United Kingdom, France, Germany, Italy, Spain, Sweden, Switzerland, Norway, Netherlands, United States, Canada, Japan, Korea, Singapore, Malaysia, India, China, Thailand, Indonesia)
Cervical Cancer Screening Market & Population - the report studies all 3 types of Test
- Pap Smear Tests Market
- HPV DNA Tests Market
- VIA Tests Market
Cervical Cancer Mortality Population
In this section number of deaths by cervical cancer in all the 19 countries from 2014 to 2020 has been captured. The report gives complete insights of Market, Screened Population & Mortality of 19 countries, which provides a general idea of worldwide countries analysis of Global Cervical Cancer Screening Industry.
1. United Kingdom
2. France
3. Germany
4. Italy
5. Spain
6. Sweden
7. Switzerland
8. Norway
9. Netherlands
10. United States
11. Canada
12. Japan
13. Korea
14. Singapore
15. Malaysia
16. India
17. China
18. Thailand
19. Indonesia
Table of Contents
Countries Covered
- Canada
- China
- France
- Germany
- India
- Indonesia
- Italy
- Japan
- Korea
- Malaysia
- Netherlands
- Norway
- Singapore
- Spain
- Sweden
- Switzerland
- Thailand
- United Kingdom
- United States
Methodology
In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.
Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.
Primary Research
The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develop the analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth, and forecast
The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:
- Chief executives and VPs of leading corporations specific to the industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
- Key opinion leaders (KOLs)
Secondary Research
The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, webcasts, and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
LOADING...
